|
Market Closed -
Bombay S.E.
09:02:27 26/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 2,448.15 INR | +1.80% |
|
-4.56% | -0.92% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 415B 4.36B 3.9B 3.61B 3.27B 6.11B 6.21B 43.4B 17.17B 217B 16.36B 16.01B 687B | P/E 2027 * |
35.6x | P/E 2028 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise Value | 415B 4.36B 3.9B 3.61B 3.27B 6.11B 6.21B 43.4B 17.17B 217B 16.36B 16.01B 687B | EV / Sales 2027 * |
9.74x | EV / Sales 2028 * | 8.78x |
| Free-Float |
24.37% | Yield 2027 * |
1.2% | Yield 2028 * | 1.2% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +1.80% | ||
| 1 week | -4.56% | ||
| Current month | -11.54% | ||
| 1 month | -13.09% | ||
| 3 months | -2.59% | ||
| 6 months | -1.01% | ||
| Current year | -0.92% |
| 1 week | 2,342.7 |  | 2,509 |
| 1 month | 2,342.7 | | 2,986.65 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -4.56% | -10.98% | +67.56% | 4.29B | |
| +0.45% | +1.76% | +54.96% | +118.11% | 1,135B | |
| +0.94% | +4.20% | +39.86% | +75.69% | 635B | |
| +0.39% | +0.46% | +25.77% | +97.40% | 505B | |
| +1.43% | +4.56% | +46.20% | +66.91% | 378B | |
| -3.21% | -3.66% | +60.72% | +35.68% | 358B | |
| -0.41% | +2.23% | +22.48% | +48.54% | 295B | |
| +0.23% | +3.28% | +2.57% | +21.89% | 266B | |
| +1.22% | +2.81% | +52.40% | +63.37% | 237B | |
| +1.70% | +1.60% | +31.21% | +102.44% | 193B | |
| Average | +0.40% | +0.82% | +32.52% | +69.76% | 400.79B | |
| Weighted average by Cap. | +0.26% | +1.62% | +41.34% | +81.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 447M 400M 370M 335M 627M 638M 4.45B 1.76B 22.26B 1.68B 1.64B 70.5B | 47.24B 497M 444M 411M 372M 696M 708M 4.94B 1.96B 24.71B 1.86B 1.82B 78.23B |
| Net income | 11.65B 122M 110M 101M 91.75M 172M 175M 1.22B 482M 6.1B 460M 450M 19.3B | 13.42B 141M 126M 117M 106M 198M 201M 1.4B 555M 7.02B 529M 518M 22.22B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | INR 2,448.15 | +1.80% | 2,133 |
| 23/10/26 | INR 2,404.80 | -1.23% | 3,432 |
| 22/10/26 | INR 2,434.70 | -1.18% | 1,430 |
| 21/10/26 | INR 2,463.75 | -1.04% | 2,472 |
| 19/10/26 | INR 2,489.70 | -2.94% | 1,124 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
